13F HOLDINGS REPORT
Soleus Capital Management, L.P.
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001802630-24-000005
Total Value
$1.35B
Positions
91
Other Managers
0
Confidential Omitted
No
Holdings (91)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78464A870 | 2,200,000 | $208.8M | 15.49% |
| 2 | UNITED THERAPEUTICS CORP DEL | UTHR | 259,749 | $59.7M | 4.43% |
| 3 | EDAP TMS S A | EDAP | 7,227,353 | $53.1M | 3.94% |
| 4 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 3,505,000 | $51.9M | 3.86% |
| 5 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 3,486,440 | $49.2M | 3.65% |
| 6 | TG THERAPEUTICS INC | TGTX | 3,168,456 | $48.2M | 3.58% |
| 7 | CELCUITY INC | CELC | 1,731,338 | $37.4M | 2.78% |
| 8 | JASPER THERAPEUTICS INC | JSPRW | 1,187,096 | $34.9M | 2.59% |
| 9 | NEUROPACE INC | NPCE | 2,433,168 | $32.1M | 2.38% |
| 10 | ESSA PHARMA INC | 29668H708 | 3,589,558 | $30.5M | 2.26% |
| 11 | ORGANOGENESIS HLDGS INC | ORGO | 9,573,198 | $27.2M | 2.02% |
| 12 | AXOGEN INC | AXGN | 3,105,815 | $25.1M | 1.86% |
| 13 | HUMANA INC | HUM | 72,006 | $25.0M | 1.85% |
| 14 | SURMODICS INC | 868873100 | 800,820 | $23.5M | 1.74% |
| 15 | REVOLUTION MEDICINES INC | RVMDW | 728,700 | $23.5M | 1.74% |
| 16 | IDEAYA BIOSCIENCES INC | IDYA | 533,515 | $23.4M | 1.74% |
| 17 | BEIGENE LTD | BEIGF | 148,100 | $23.2M | 1.72% |
| 18 | C4 THERAPEUTICS INC | CCCC | 2,458,996 | $20.1M | 1.49% |
| 19 | PENUMBRA INC | PEN | 85,700 | $19.1M | 1.42% |
| 20 | VERASTEM INC | VSTM | 1,540,634 | $18.2M | 1.35% |
| 21 | KEROS THERAPEUTICS INC | KROS | 273,600 | $18.1M | 1.34% |
| 22 | TREACE MED CONCEPTS INC | 89455T109 | 1,345,648 | $17.6M | 1.30% |
| 23 | HCA HEALTHCARE INC | HCA | 51,441 | $17.2M | 1.27% |
| 24 | NURIX THERAPEUTICS INC | NRIX | 1,115,000 | $16.4M | 1.22% |
| 25 | CASTLE BIOSCIENCES INC | CSTL | 725,457 | $16.1M | 1.19% |
| 26 | IRADIMED CORP | IRMD | 361,630 | $15.9M | 1.18% |
| 27 | BIOGEN INC | BIIB | 72,800 | $15.7M | 1.17% |
| 28 | KRYSTAL BIOTECH INC | KRYS | 84,100 | $15.0M | 1.11% |
| 29 | VAXCYTE INC | PCVX | 207,750 | $14.2M | 1.05% |
| 30 | BIOATLA INC | BCAB | 4,065,197 | $14.0M | 1.04% |
| 31 | GSK PLC | GLAXF | 319,217 | $13.7M | 1.02% |
| 32 | RIGEL PHARMACEUTICALS INC | RIGL | 9,241,986 | $13.7M | 1.02% |
| 33 | ENGENE HOLDINGS INC | ENGNW | 800,000 | $13.6M | 1.01% |
| 34 | INARI MED INC | 45332Y109 | 277,000 | $13.3M | 0.99% |
| 35 | NOVOCURE LTD | NVCR | 695,759 | $10.9M | 0.81% |
| 36 | TANGO THERAPEUTICS INC | TNGX | 1,350,145 | $10.7M | 0.80% |
| 37 | APPLIED THERAPEUTICS INC | 03828A101 | 1,564,916 | $10.6M | 0.79% |
| 38 | ARCELLX INC | ACLX | 150,000 | $10.4M | 0.77% |
| 39 | ENANTA PHARMACEUTICALS INC | ENTA | 580,546 | $10.1M | 0.75% |
| 40 | NUVALENT INC | NUVL | 129,288 | $9.7M | 0.72% |
| 41 | IMMUNIC INC | IMUX | 7,293,007 | $9.6M | 0.71% |
| 42 | CG ONCOLOGY INC | CGON | 217,871 | $9.6M | 0.71% |
| 43 | INHIBRX INC | INBX | 267,871 | $9.4M | 0.70% |
| 44 | PHARVARIS N V | PHVS | 401,901 | $9.3M | 0.69% |
| 45 | Y-MABS THERAPEUTICS INC | 984241109 | 570,982 | $9.3M | 0.69% |
| 46 | MERUS N V | N5749R100 | 195,577 | $8.8M | 0.65% |
| 47 | SYNDAX PHARMACEUTICALS INC | SNDX | 369,000 | $8.8M | 0.65% |
| 48 | MEREO BIOPHARMA GROUP PLC | MREO | 2,616,953 | $8.6M | 0.64% |
| 49 | IMMUNOVANT INC | IMVT | 264,650 | $8.6M | 0.63% |
| 50 | THERATECHNOLOGIES INC | 88338H704 | 4,801,376 | $8.0M | 0.59% |
| 51 | NATERA INC | NTRA | 87,000 | $8.0M | 0.59% |
| 52 | OLEMA PHARMACEUTICALS INC | OLMA | 658,000 | $7.4M | 0.55% |
| 53 | GENEDX HOLDINGS CORP | WGSWW | 783,376 | $7.2M | 0.53% |
| 54 | BAUSCH HEALTH COS INC | 071734107 | 670,000 | $7.1M | 0.53% |
| 55 | MANNKIND CORP | MNKD | 1,558,537 | $7.1M | 0.52% |
| 56 | MIND MEDICINE MINDMED INC | 60255C885 | 750,237 | $7.1M | 0.52% |
| 57 | INSMED INC | INSM | 250,000 | $6.8M | 0.50% |
| 58 | FATE THERAPEUTICS INC | FATE | 870,000 | $6.4M | 0.47% |
| 59 | X4 PHARMACEUTICALS INC | XFOR | 4,579,926 | $6.4M | 0.47% |
| 60 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 197,098 | $6.3M | 0.47% |
| 61 | VIRIDIAN THERAPEUTICS INC | VRDN | 340,000 | $6.0M | 0.44% |
| 62 | JANUX THERAPEUTICS INC | JANX | 157,800 | $5.9M | 0.44% |
| 63 | ORIC PHARMACEUTICALS INC | ORIC | 421,000 | $5.8M | 0.43% |
| 64 | VIKING THERAPEUTICS INC | VKTX | 67,121 | $5.5M | 0.41% |
| 65 | COMPASS PATHWAYS PLC | CMPS | 565,550 | $4.7M | 0.35% |
| 66 | KALVISTA PHARMACEUTICALS INC | KALV | 386,000 | $4.6M | 0.34% |
| 67 | REGULUS THERAPEUTICS INC | 75915K309 | 1,562,500 | $4.5M | 0.33% |
| 68 | BICYCLE THERAPEUTICS PLC | BCYC | 153,000 | $3.8M | 0.28% |
| 69 | INSPIREMD INC | NSPR | 1,378,128 | $3.3M | 0.24% |
| 70 | CALCIMEDICA INC | CALC | 783,904 | $3.3M | 0.24% |
| 71 | NKARTA INC | NKTX | 300,000 | $3.2M | 0.24% |
| 72 | DIANTHUS THERAPEUTICS INC | DNTH | 100,000 | $3.0M | 0.22% |
| 73 | CERVOMED INC | CRVO | 126,614 | $3.0M | 0.22% |
| 74 | TAYSHA GENE THERAPIES INC | TSHA | 925,000 | $2.7M | 0.20% |
| 75 | PRAXIS PRECISION MEDICINES I | PRAX | 37,268 | $2.3M | 0.17% |
| 76 | EVOLUS INC | EOLS | 160,000 | $2.2M | 0.17% |
| 77 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 225,000 | $2.2M | 0.17% |
| 78 | ANNEXON INC | ANNX | 292,400 | $2.1M | 0.16% |
| 79 | APOGEE THERAPEUTICS INC | APGE | 20,000 | $1.3M | 0.10% |
| 80 | TRANSMEDICS GROUP INC | TMDX | 16,700 | $1.2M | 0.09% |
| 81 | AVITA MEDICAL INC | AVHHL | 75,000 | $1.2M | 0.09% |
| 82 | PROTAGONIST THERAPEUTICS INC | PTGX | 34,500 | $998,085 | 0.07% |
| 83 | DENALI THERAPEUTICS INC | DNLI | 47,000 | $964,440 | 0.07% |
| 84 | CVRX INC | CVRX | 48,500 | $883,185 | 0.07% |
| 85 | THE BEAUTY HEALTH COMPANY | 88331L108 | 170,000 | $754,800 | 0.06% |
| 86 | AMICUS THERAPEUTICS INC | FOLD | 57,966 | $682,839 | 0.05% |
| 87 | TENAYA THERAPEUTICS INC | TNYA | 122,222 | $639,221 | 0.05% |
| 88 | SILK RD MED INC | 82710M100 | 10,000 | $183,200 | 0.01% |
| 89 | UROGEN PHARMA LTD | URGN | 10,000 | $150,000 | 0.01% |
| 90 | LIQUIDIA CORPORATION | LQDA | 10,000 | $147,500 | 0.01% |
| 91 | XERIS BIOPHARMA HOLDINGS INC | XERS | 62,083 | $137,203 | 0.01% |